[1] Takahashi K, Takeya M, Sakashita N. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals[J]. Med Electron Microsc, 2002; 35(4): 179-203. [2] Brasier AR,?Recinos A 3rd,?Eledrisi MS. Vascular inflammation and the rennin-angiotensin system[J]. Arterioscler Thromb Vasc Biol, 2002; 22(8):1257-1266.[3] Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9[J]. Circ Res, 2000; 87(5): E1-9.[4] Sluimer JC, Gasc JM, Hamming I, et al. Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions[J]. Pathology, 2008; 215(5):273-279.[5] Tikellis C, Bernardi S, Burns WC. Angiotensin-converting enzyme 2 is a key modulator of the rennin- angiotensin system in cardiovascular and renal disease[J]. Curr Opin Nephrol Hypertens, 2011; 20(1): 62-68.[6] Peltonena T, N?p?nkangas J, Ohtonen P, et al. (Pro)renin receptors and angiotensin converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in human aortic valve stenosis[J]. Atherosclerosis, 2011; 216(1): 35-43.[7] Santos RA, Simoes e Silva AC, Maric C, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas[J]. Proc Natl Acad Sci USA, 2003; 100(14):8258-8263.[8] 唐颖, 倪兵, 陈代杰. 巨噬细胞泡沫化抑制剂的研究进展[J].中国新药与临床杂志, 2005; 24(11): 903-905.[9] Kita T,Kume N, Minami M, et al. Role of oxidized LDL in atherosclerosis[J]. Ann N Y Aca Sci, 2001; 947:199-205.[10] 姚树桐, 桑 慧, 杨娜娜等. 氧化低密度脂蛋白诱导巨噬细胞内质网应激及CD36的可能作用[J]. 生理学报, 2010; 62(5): 433-440.[11] 卢卓强. ACE2-Ang-(1-7)-Mas轴:血管疾病治疗的新靶点[J]. 国际心血管病杂志, 2009; 36(1): 25-27.[12] Thomas MC,?Pickering RJ,?Tsorotes D,?et al. Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse[J]. Circ Res, 2010; 107(7): 888-897.[13] Rabelo LA, Alenina N, Bader M, et al. ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease. Hypertens Res, 2011; 34(2):154-160.[14] Yang JM, Dong M, Meng X, et al. Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells. Arterioscler Thromb Vasc Biol, 2013; 33(8):1978-1985.[15] Gwathmey TM, Pendergrass KD, Reid SD, et al. Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensinⅡwithin the cell nucleus[J]. Hypertensio, 2010; 55(1):166-171.[16] Liao X, Wang L, Yang C, et al. Cyclooxygenase mediates cardioprotection of angiotensin-(1-7) against ischemia/reperfusion-induced injury through the inhibition of oxidative stress[J]. Mol Med Rep, 2011; 4(6):1145-1150.[17] Yang XH, Wang YH, Wang JJ, et al. Role of angiotensin-converting enzyme (ACE and ACE2) imbalance on tourniquet-induced remote kidney injury in a mouse hindlimb ischemia-reperfusion model[J]. Peptides. 2012; 36(1):60-70.[18] 李亚芯,徐晨阳,张东慧等. 血管紧张素转移酶2(ACE2)在糖尿病致大鼠肝脏氧化应激损伤中的作用及机制分析[J]. 食品科学, 2013; 34(07):279-283. |